UCBJY
Price
$145.97
Change
-$2.80 (-1.88%)
Updated
Oct 17 closing price
Capitalization
56.58B
10 days until earnings call
Intraday Buy/Sell Signals
VANI
Price
$1.69
Change
+$0.21 (+14.19%)
Updated
Oct 17 closing price
Capitalization
100.12M
31 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

UCBJY vs VANI

Header iconUCBJY vs VANI Comparison
Open Charts UCBJY vs VANIBanner chart's image
UCB S.A
Price$145.97
Change-$2.80 (-1.88%)
Volume$33.13K
Capitalization56.58B
Vivani Medical
Price$1.69
Change+$0.21 (+14.19%)
Volume$1.14M
Capitalization100.12M
UCBJY vs VANI Comparison Chart in %
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
UCBJY vs. VANI commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UCBJY is a Hold and VANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (UCBJY: $145.97 vs. VANI: $1.69)
Brand notoriety: UCBJY and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: UCBJY: 102% vs. VANI: 717%
Market capitalization -- UCBJY: $56.58B vs. VANI: $100.12M
UCBJY [@Biotechnology] is valued at $56.58B. VANI’s [@Biotechnology] market capitalization is $100.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

UCBJY’s FA Score shows that 2 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • UCBJY’s FA Score: 2 green, 3 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, UCBJY is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UCBJY’s TA Score shows that 2 TA indicator(s) are bullish while VANI’s TA Score has 7 bullish TA indicator(s).

  • UCBJY’s TA Score: 2 bullish, 6 bearish.
  • VANI’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, VANI is a better buy in the short-term than UCBJY.

Price Growth

UCBJY (@Biotechnology) experienced а -1.99% price change this week, while VANI (@Biotechnology) price change was +23.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

UCBJY is expected to report earnings on Oct 28, 2025.

VANI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UCBJY($56.6B) has a higher market cap than VANI($100M). UCBJY YTD gains are higher at: 49.031 vs. VANI (45.690). UCBJY has higher annual earnings (EBITDA): 2.34B vs. VANI (-26.38M). UCBJY has more cash in the bank: 2.01B vs. VANI (6.79M). VANI has less debt than UCBJY: VANI (18.6M) vs UCBJY (2.88B). UCBJY has higher revenues than VANI: UCBJY (6.85B) vs VANI (0).
UCBJYVANIUCBJY / VANI
Capitalization56.6B100M56,600%
EBITDA2.34B-26.38M-8,884%
Gain YTD49.03145.690107%
P/E Ratio36.54N/A-
Revenue6.85B0-
Total Cash2.01B6.79M29,614%
Total Debt2.88B18.6M15,473%
FUNDAMENTALS RATINGS
UCBJY vs VANI: Fundamental Ratings
UCBJY
VANI
OUTLOOK RATING
1..100
806
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
9100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
3843
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5029

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UCBJY's Valuation (3) in the null industry is somewhat better than the same rating for VANI (65). This means that UCBJY’s stock grew somewhat faster than VANI’s over the last 12 months.

UCBJY's Profit vs Risk Rating (9) in the null industry is significantly better than the same rating for VANI (100). This means that UCBJY’s stock grew significantly faster than VANI’s over the last 12 months.

UCBJY's SMR Rating (92) in the null industry is in the same range as VANI (100). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

UCBJY's Price Growth Rating (38) in the null industry is in the same range as VANI (43). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

UCBJY's P/E Growth Rating (100) in the null industry is in the same range as VANI (100). This means that UCBJY’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
UCBJYVANI
RSI
ODDS (%)
Bearish Trend 2 days ago
27%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
69%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
28%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APPN28.150.36
+1.30%
Appian Corp
BAX23.090.12
+0.52%
Baxter International
MLR40.16-0.50
-1.23%
Miller Industries
UCL2.18-0.03
-1.36%
uCloudlink Group
TOVX0.42-0.01
-2.32%
Theriva Biologics Inc

UCBJY and

Correlation & Price change

A.I.dvisor tells us that UCBJY and GBIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
-1.88%
GBIO - UCBJY
28%
Poorly correlated
-6.93%
VANI - UCBJY
26%
Poorly correlated
+14.19%
ABOS - UCBJY
24%
Poorly correlated
-4.69%
TNYA - UCBJY
23%
Poorly correlated
-2.69%
ARWR - UCBJY
23%
Poorly correlated
-5.54%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
+14.19%
VTVT - VANI
60%
Loosely correlated
-2.69%
ADIL - VANI
37%
Loosely correlated
-3.36%
AXSM - VANI
36%
Loosely correlated
+2.35%
SCNI - VANI
34%
Loosely correlated
-4.11%
KYTX - VANI
29%
Poorly correlated
-5.42%
More